408 related articles for article (PubMed ID: 24015033)
41. EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.
Boye K; Nesland JM; Sandstad B; Haugland Haugen M; Mælandsmo GM; Flatmark K
Br J Cancer; 2012 Aug; 107(4):667-74. PubMed ID: 22782346
[TBL] [Abstract][Full Text] [Related]
42. The relationship between cancer associated fibroblasts biomarkers and prognosis of breast cancer: a systematic review and meta-analysis.
Cui M; Dong H; Duan W; Wang X; Liu Y; Shi L; Zhang B
PeerJ; 2024; 12():e16958. PubMed ID: 38410801
[TBL] [Abstract][Full Text] [Related]
43. Expression of protein S100A4 is a predictor of recurrence in colorectal cancer.
Kwak JM; Lee HJ; Kim SH; Kim HK; Mok YJ; Park YT; Choi JS; Moon HY
World J Gastroenterol; 2010 Aug; 16(31):3897-904. PubMed ID: 20712050
[TBL] [Abstract][Full Text] [Related]
44. Simultaneous Expression of CD70 and POSTN in Cancer-Associated Fibroblasts Predicts Worse Survival of Colorectal Cancer Patients.
Komura M; Wang C; Ito S; Kato S; Ueki A; Ebi M; Ogasawara N; Tsuzuki T; Kasai K; Kasugai K; Takiguchi S; Takahashi S; Inaguma S
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473788
[TBL] [Abstract][Full Text] [Related]
45. Periostin- and podoplanin-positive cancer-associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma.
Neuzillet C; Nicolle R; Raffenne J; Tijeras-Raballand A; Brunel A; Astorgues-Xerri L; Vacher S; Arbateraz F; Fanjul M; Hilmi M; Samain R; Klein C; Perraud A; Rebours V; Mathonnet M; Bièche I; Kocher H; Cros J; Bousquet C
J Pathol; 2022 Dec; 258(4):408-425. PubMed ID: 36102377
[TBL] [Abstract][Full Text] [Related]
46. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
[TBL] [Abstract][Full Text] [Related]
47. Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.
Boye K; Jacob H; Frikstad KA; Nesland JM; Maelandsmo GM; Dahl O; Nesbakken A; Flatmark K
Cancer Med; 2016 Aug; 5(8):1840-9. PubMed ID: 27273130
[TBL] [Abstract][Full Text] [Related]
48. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
Dahlmann M; Okhrimenko A; Marcinkowski P; Osterland M; Herrmann P; Smith J; Heizmann CW; Schlag PM; Stein U
Oncotarget; 2014 May; 5(10):3220-33. PubMed ID: 24952599
[TBL] [Abstract][Full Text] [Related]
49. Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma.
Kawase A; Ishii G; Nagai K; Ito T; Nagano T; Murata Y; Hishida T; Nishimura M; Yoshida J; Suzuki K; Ochiai A
Int J Cancer; 2008 Sep; 123(5):1053-9. PubMed ID: 18546264
[TBL] [Abstract][Full Text] [Related]
50. Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4.
Hanley CJ; Mellone M; Ford K; Thirdborough SM; Mellows T; Frampton SJ; Smith DM; Harden E; Szyndralewiez C; Bullock M; Noble F; Moutasim KA; King EV; Vijayanand P; Mirnezami AH; Underwood TJ; Ottensmeier CH; Thomas GJ
J Natl Cancer Inst; 2018 Jan; 110(1):109-20. PubMed ID: 28922779
[TBL] [Abstract][Full Text] [Related]
51. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma.
Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A
Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451
[TBL] [Abstract][Full Text] [Related]
52. D2-40/podoplanin expression in cancer stroma by immunohistochemical staining is associated with poor prognosis in bladder cancer patients after radical cystectomy.
Okajima E; Tomizawa M; Shimada K; Negishi T; Nishiyama N; Kitamura H
Urol Oncol; 2020 Oct; 38(10):797.e7-797.e13. PubMed ID: 32576528
[TBL] [Abstract][Full Text] [Related]
53. Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer.
Sugai T; Yamada N; Osakabe M; Hashimoto M; Uesugi N; Eizuka M; Tanaka Y; Sugimoto R; Yanagawa N; Matsumoto T
Histopathology; 2021 Oct; 79(4):584-598. PubMed ID: 33884652
[TBL] [Abstract][Full Text] [Related]
54. Metastasis-associated protein S100A4--a potential prognostic marker for colorectal cancer.
Hemandas AK; Salto-Tellez M; Maricar SH; Leong AF; Leow CK
J Surg Oncol; 2006 May; 93(6):498-503. PubMed ID: 16615153
[TBL] [Abstract][Full Text] [Related]
55. Prognostic significance of calcium-binding protein S100A4 in colorectal cancer.
Gongoll S; Peters G; Mengel M; Piso P; Klempnauer J; Kreipe H; von Wasielewski R
Gastroenterology; 2002 Nov; 123(5):1478-84. PubMed ID: 12404222
[TBL] [Abstract][Full Text] [Related]
56. CD66b
Cong X; Zhang Y; Zhu Z; Li S; Yin X; Zhai Z; Zhang Y; Xue Y
Cancer Med; 2020 Apr; 9(8):2761-2773. PubMed ID: 32096331
[TBL] [Abstract][Full Text] [Related]
57. Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 - negative subtype.
Tanaka Y; Ohno T; Kadonaga T; Kidokoro Y; Wakahara M; Nosaka K; Sakabe T; Suzuki Y; Nakamura H; Umekita Y
Breast Cancer; 2021 Jul; 28(4):822-828. PubMed ID: 33481184
[TBL] [Abstract][Full Text] [Related]
58. Expression of Podoplanin in Mammary Cancers in Female Dogs.
Borecka P; Ciaputa R; Janus I; Piotrowska A; Ratajczak-Wielgomas K; Kmiecik A; Podhorska-Okolów M; Dzięgiel P; Nowak M
In Vivo; 2020; 34(1):213-223. PubMed ID: 31882481
[TBL] [Abstract][Full Text] [Related]
59. Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.
Chuang WY; Yeh CJ; Chao YK; Liu YH; Chang YS; Tseng CK; Chang HK; Wan YL; Hsueh C
Int J Clin Exp Pathol; 2014; 7(8):4847-56. PubMed ID: 25197355
[TBL] [Abstract][Full Text] [Related]
60. Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I-III NSCLC.
Schulze AB; Schmidt LH; Heitkötter B; Huss S; Mohr M; Marra A; Hillejan L; Görlich D; Barth PJ; Rehkämper J; Evers G
Thorac Cancer; 2020 Jan; 11(1):120-129. PubMed ID: 31760702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
